PARSORTIX
LIVE

Serial Number

87140221

Owner

CELLBXHEALTH EUROPE LIMITED

Attorney

Christina M. Licursi

Filing Date

Aug 16, 2016

Add to watchlist:

No watchlists yet
View on USPTO

PARSORTIX Trademark

Serial Number: 87140221 • Registration: 5425872

PARSORTIX is a trademark filed by CELLBXHEALTH EUROPE LIMITED on August 16, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

CELLBXHEALTH EUROPE LIMITED

10 NUGENT ROAD, THE SURREY RESEARCH PARK
GUILDFORD GU2 7AF , GB

Entity Type: 11

Angle Europe Limited

10 Nugent Road,

Entity Type: 99

Trademark Details

Filing Date

August 16, 2016

Registration Date

March 20, 2018

Published for Opposition

January 2, 2018

Goods & Services

[ Medical diagnostic apparatus, equipment and instruments for diagnosis of clinical conditions involving the presence of solid tissue cells in blood; ] medical testing apparatus, equipment and instruments, namely, medical diagnostic apparatus for testing body fluids including blood and plasma, cancer cells; [ fetal cells; ] parts and fittings for the aforesaid goods; diagnostic apparatus, equipment and instruments for cytology and histology, all for use in detecting cancer

[ Medical diagnostic reagents and assay components for testing of body fluids including blood and plasma, and cells; medical diagnostic kits comprised of diagnostic reagents and assay components for testing of body fluids including blood and plasma, and cells for medical purposes; all the aforesaid goods not including any such goods that are prescription only pharmaceuticals; biomarkers, namely, diagnostic biomarker reagents for medical purposes; diagnostic reagent kits consisting primarily of medical diagnostic reagents and assays, for use in detecting cancerous conditions and other conditions involving somatic genetic changes; medical testing kits comprising reagents to assay biochemicals including nucleic acids and proteins, for use in detecting cancerous conditions and other conditions involving somatic genetic changes for medical purposes ]

[ Diagnostic preparations and reagents for scientific or research use; Chemical reagents for non-medical purposes; reagents for in vitro use for scientific or medical research; buffer solutions and reagents for use in diagnostic analysis and research with laboratory apparatus, namely, separation apparatus and analysis apparatus; biomarkers, namely, nucleic acid, protein and other biochemical ligands for scientific or research use; diagnostic kits comprised of diagnostic reagents and assay components for clinical and medical laboratory use ]

Apparatus, equipment and instruments for scientific, laboratory, diagnostic or general research use, namely, laboratory vessels, analyzers, pre-packed columns for use in separation and purification, glassware, tubes including sample tubes, reagent tubes; [ phlebotomy tubes and eppendorf tubes; ] apparatus, equipment and instruments for cytology, histology and for use in detecting cancerous conditions for laboratory or research use; apparatus in the nature of cassettes for use in laboratory, diagnostic or general research use; cell analyzer providing quantitative cell analysis for scientific, laboratory or general research use and disposable cassettes therefor; apparatus for use in testing and analyzing blood and blood cells for laboratory or research use; [ biological analysis computer software; ] parts and fitting for the aforesaid goods; medical laboratory research instruments for use in the detection of cancer

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 13, 2026 ASGN
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Mar 28, 2025 NAS8
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
Mar 28, 2025 8.PR
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 28, 2025 APRE
TEAS SECTION 8 RECEIVED
Aug 22, 2024 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 20, 2023 REM1
REGISTERED-PRINCIPAL REGISTER
Mar 20, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 2, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jan 2, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 13, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 29, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 21, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 21, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 21, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 21, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 21, 2017 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Nov 14, 2017 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Nov 7, 2017 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 26, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 17, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 16, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 16, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 16, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 16, 2017 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Oct 10, 2017 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Sep 26, 2017 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 12, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 11, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 11, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 11, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 11, 2017 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 23, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 23, 2017 CRFA
ASSIGNED TO LIE
Aug 22, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 1, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 7, 2017 GNRN
NON-FINAL ACTION E-MAILED
Mar 7, 2017 GNRT
NON-FINAL ACTION WRITTEN
Mar 7, 2017 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 11, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 10, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 10, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 6, 2016 GNRN
NON-FINAL ACTION E-MAILED
Dec 6, 2016 GNRT
NON-FINAL ACTION WRITTEN
Dec 6, 2016 CNRT
ASSIGNED TO EXAMINER
Nov 28, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 19, 2016 NWOS
NEW APPLICATION ENTERED
Aug 19, 2016 NWAP